As such, evolutionarily selected and/or functionally relevant polymorphisms in the CD5 and CD6 loci have been shown to impact a wide variety of immune-related disorders such as autoimmunity and cancer, often considered two sides of the same coin. The gene discussed is CD5; the disease is cancer.